| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/10/2001 | EP1066506A1 Method and apparatus for synthesis of arrays of dna probes |
| 01/10/2001 | EP1066505A1 Apparatus and method for infectious disease detection |
| 01/10/2001 | EP1066414A1 Rolling circle replication of padlock probes |
| 01/10/2001 | EP1066413A1 Polymorphism iii : linkage of atopy to a locus on chromosome 13 |
| 01/10/2001 | EP1066412A1 Polymorphism ii : linkage of asthma to a locus on chromosome 4 |
| 01/10/2001 | EP1066410A2 Amplification of nucleic acids |
| 01/10/2001 | EP1066409A1 Method for detecting damaged dna using protein complexes and elements for implementing said method |
| 01/10/2001 | EP1066408A1 A novel method of detecting and monitoring endometrial and uterine cancers |
| 01/10/2001 | EP1066407A1 A method of interstrain differentiation of bacteria |
| 01/10/2001 | EP1066406A1 Detection of proteinases by means of an enzyme as proteinase substrate |
| 01/10/2001 | EP1066405A1 Novel chromogenous substrates for detecting bacterial hydrolase |
| 01/10/2001 | EP1066403A1 Method for detecting micro-organisms in gases |
| 01/10/2001 | EP1066402A1 Methods of screening agents for activity using teleosts |
| 01/10/2001 | EP1066401A2 Anthrax lethal factor is a mapk kinase protease |
| 01/10/2001 | EP1066385A1 Plant flavanone-3-hydroxylase |
| 01/10/2001 | EP1066378A2 Lyst protein complexes and lyst interacting proteins |
| 01/10/2001 | EP1066369A1 Selection subtraction approach to gene identification |
| 01/10/2001 | EP1066368A1 Selective cell analysis |
| 01/10/2001 | EP1066323A1 Treatment and prevention of vascular disease |
| 01/10/2001 | EP1066320A1 Orphan nuclear receptor |
| 01/10/2001 | EP1066319A1 Production methods and uses of a retrovirus |
| 01/10/2001 | EP1066311A1 Compositions and methods for the identification of lung tumor cells |
| 01/10/2001 | EP1066310A1 Neokine protein and nucleic acid molecules and uses therefor |
| 01/10/2001 | EP1066042A2 Steroidal saponins for treating alzheimer's disease |
| 01/10/2001 | EP1066033A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 01/10/2001 | EP0906570B1 Process to eliminate haemoglobin errors when analysing medical samples |
| 01/10/2001 | EP0642667B1 Screening method for identifying women at increased risk for preterm delivery |
| 01/10/2001 | EP0556301B1 Incorporation of multiple reporter groups on synthetic oligonucleotides |
| 01/10/2001 | CN1279792A Control of nucleic acid amplification procedures including the polymerase chain reaction (PCR) |
| 01/10/2001 | CN1279689A Vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 01/10/2001 | CN1279687A Bi-and tri-cyclic nucleoside, nucleotide and oligonucleotide analoguse |
| 01/10/2001 | CN1279606A Use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 01/10/2001 | CN1279292A Phytolipoase table for quickly detecting agricultural chemical of organophosphorus |
| 01/10/2001 | CN1279290A Human signal recognition particle receptor beta and its coding sequence, preparing process and application |
| 01/10/2001 | CN1279289A Human P47 protein and its coding sequence |
| 01/09/2001 | US6172279 Plant gene construct encoding a protein capable of disrupting the biogenesis of viable pollen |
| 01/09/2001 | US6172218 Oligonucleotide tags for sorting and identification |
| 01/09/2001 | US6172215 Nucleotide sequences which hybridize preferentially to microorganismal nucleotide sequences; screening for preferential microorganisms which cause gastrointestinal disorders |
| 01/09/2001 | US6172214 Oligonucleotide tags for sorting and identification |
| 01/09/2001 | US6172211 Nucleotide sequences which codes a protein that modulates tumor propagation; for the treatment of cancer; antitumor agents; anticarcinogenic agents; antiproliferative agents |
| 01/09/2001 | US6172208 Oligonucleotides modified with conjugate groups |
| 01/09/2001 | US6172200 Monoclonal antibody that preferentially binds protein; for use as diagnostic tool in analyzing embryonic development and cellular regulation; for the detection of modulators of gene expression |
| 01/09/2001 | US6172199 Human ubiquitin-conjugating enzyme |
| 01/09/2001 | US6172194 ARF-p19, a novel regulator of the mammalian cell cycle |
| 01/09/2001 | US6172193 Escape mutant of the surface antigen of hepatitis B virus |
| 01/09/2001 | US6172192 Polypeptide or peptide associated microorganism infection; for diagnosis and prevention protozoan infection of mammals |
| 01/09/2001 | US6172188 Fluorescent proteins |
| 01/09/2001 | US6172184 Genetically engineered protein; for generating disease resistance plants and to amplify plant propagation; for biological pest control |
| 01/09/2001 | US6171860 Oligonucleotides which target untranslated regions and start codons to prevent transcription of a gene; for treatment of bone disorders, inflammation and cancer; antiinflammatory agents; anticarcinogenic agents; antitumor agents |
| 01/09/2001 | US6171859 Defective cytochrome c oxidase; diagnosing alzheimer*s disease |
| 01/09/2001 | US6171851 Apparatus for monitoring protein catalytic activity in extracts from plants, bacteria, body fluids and tissue homegenates |
| 01/09/2001 | US6171849 Apparatus for separating high density lipoprotein from a lipoprotein containing body fluid; for the separation of lipoproteins in sample |
| 01/09/2001 | US6171845 Mutant E. coli kiz strains for production of pantothenic acid |
| 01/09/2001 | US6171840 LacC from streptococcus pneumoniae |
| 01/09/2001 | US6171838 ratB |
| 01/09/2001 | US6171834 Muri protein from Streptococcus pneumoniae |
| 01/09/2001 | US6171821 Screening for compounds which modulate cap-independent protein translation by exposing x-linked inhibitor of apoptosis internal ribosome entry site reporter cistron with test compound and determining change in amount of translation |
| 01/09/2001 | US6171820 Saturation mutagenesis in directed evolution |
| 01/09/2001 | US6171815 Human sulfonylurea receptor |
| 01/09/2001 | US6171811 Method and kit for detecting Helicobacter pylori |
| 01/09/2001 | US6171810 Method for detecting and assaying exoglycosidase activity |
| 01/09/2001 | US6171809 Method and compositions for detecting luciferase biological samples |
| 01/09/2001 | US6171808 Mutant luciferases |
| 01/09/2001 | US6171807 Mixing together endotoxin neutralizing protein, urea, and fluorescein n-hydroxysuccinimide ester in an aqueous citrate buffer solution, and isolating the labeled protein; for use in testing |
| 01/09/2001 | US6171806 Isolated peptide defined by SEQ ID NO: 17 and uses thereof |
| 01/09/2001 | US6171803 Drug screening for allergy treatments by engineering expression of alpha, beta, and gamma subunits of receptor in host cell, incubating with candidate inhibitor, and analyzing for cell expression or cell activation |
| 01/09/2001 | US6171798 Diagnosing cancer or determining p53 status in a sample by comparing level of expression of specific genes to control; lower level indicates cancer |
| 01/09/2001 | US6171796 Biomarkers and targets for diagnosis prognosis and management of prostate disease |
| 01/09/2001 | US6171795 Nucleic acid ligands to CD40ligand |
| 01/09/2001 | US6171794 Comparing dissociation curve for the hybridization to a dissociation profile of the reference polynucleotide; to identify the fraction of sequences which are perfectly complementary to a probe |
| 01/09/2001 | US6171793 Method for scanning gene probe array to produce data having dynamic range that exceeds that of scanner |
| 01/09/2001 | US6171792 Detection systems for registering protein interactions and functional relationships |
| 01/09/2001 | US6171790 Human protease associated proteins |
| 01/09/2001 | US6171789 Nucleotide sequence |
| 01/09/2001 | US6171788 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 01/09/2001 | US6171787 Detecting polynucleotide of tumor necrosis factor-gamma in sample by contacting with polynucleotide of defined nucleotide sequence and determining binding/hybridization; diagnosis of inflammation and related disorders |
| 01/09/2001 | US6171786 Contacting cell with phosphoinositol-dependent phospholipase c inhibitor along with cytotoxic drug |
| 01/09/2001 | US6171785 Methods and devices for hemogeneous nucleic acid amplification and detector |
| 01/09/2001 | US6171784 Process for typing of HCV isolates |
| 01/09/2001 | US6171782 Antibody compositions to HCV and uses thereof |
| 01/09/2001 | US6171781 NF-AT polypeptides and polynucleotides |
| 01/09/2001 | US6171779 HMGI proteins in cancer |
| 01/09/2001 | US6171777 Decontaminating by contacting with compound, then recovering product; deactivates human immunodeficiency and hepatitis viruses; before transfusions or clinical tests |
| 01/09/2001 | US6171588 Anti-αvβ3 integrin antibody antagonists |
| 01/09/2001 | CA2082842C Nucleic acid target generation |
| 01/09/2001 | CA2017269C Fluorogenic benzoxazoles |
| 01/04/2001 | WO2001001147A1 Assay for degp protease inhibitors |
| 01/04/2001 | WO2001001144A2 Hybridization of target dna with immobilized nucleic acid analogs |
| 01/04/2001 | WO2001001142A2 Arrays of biopolymeric agents and method for their production and use |
| 01/04/2001 | WO2001001141A1 Combinatorial library with particle classes that can be distinguished by two features e.g. size, density, color, etc. |
| 01/04/2001 | WO2001001138A1 Fluorescent intensity method for assaying binding between proteins or peptides |
| 01/04/2001 | WO2001001134A1 A method for diagnosing selected adenocarcinomas |
| 01/04/2001 | WO2001001131A1 Screening methods for compounds that affect melanogenesis |
| 01/04/2001 | WO2001001129A2 Reverse transcriptase assay kit, use thereof and method for analysis of rt activity in biological samples |
| 01/04/2001 | WO2001001025A2 Microfabricated elastomeric valve and pump systems |
| 01/04/2001 | WO2001000882A1 Molecular correlates of schizophrenia and methods of diagnosing schizophrenia via these molecular correlates |
| 01/04/2001 | WO2001000880A2 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype |
| 01/04/2001 | WO2001000879A1 Novel kinases and uses thereof |
| 01/04/2001 | WO2001000877A2 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 01/04/2001 | WO2001000876A1 Nanoparticles having oligonucleotides attached thereto and uses therefor |